TNFRSF17 and Miyoshi myopathy: This compact NKCE (15-23 kDa), consisting of CD16a- and BCMA-specific affibodies connected by a linker, has demonstrated potent efficacy in activating primary NK cells, initiating synapse formation, and specifically lysing MM cells (58).